Esperion Therapeutics
ESPR
#7491
Rank
โ‚ฌ0.30 B
Marketcap
1,53ย โ‚ฌ
Share price
5.70%
Change (1 day)
-20.06%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -2,68ย โ‚ฌ

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -2,58ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -3,25ย โ‚ฌ an increase over its 2021 EPS that were of -8,76ย โ‚ฌ.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-2,68ย โ‚ฌ-17.62%
2022-3,25ย โ‚ฌ-62.87%
2021-8,76ย โ‚ฌ80.38%
2020-4,86ย โ‚ฌ50.14%
2019-3,24ย โ‚ฌ-53.18%
2018-6,91ย โ‚ฌ7.41%
2017-6,43ย โ‚ฌ110.81%
2016-3,05ย โ‚ฌ47.35%
2015-2,07ย โ‚ฌ0.89%
2014-2,05ย โ‚ฌ28.84%
2013-1,59ย โ‚ฌ-89.3%
2012-14,89ย โ‚ฌ
2002-6,27ย โ‚ฌ8.89%
2001-5,76ย โ‚ฌ-83.77%
2000-35,51ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-9,38ย โ‚ฌ 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
0,71ย โ‚ฌ-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
1,70ย โ‚ฌ-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
34,24ย โ‚ฌ-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,59ย โ‚ฌ-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-0,62ย โ‚ฌ-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA